Karuna Therapeutics Inc.

NASDAQ: KRTX · Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM

Karuna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-433.68M -276.34M -143.81M
Depreciation & Amortization
1.7M 1.11M 506K
Stock-Based Compensation
74.6M 47.45M 29.81M
Other Working Capital
5.12M 2.84M 11.52M
Other Non-Cash Items
-37.97M -5.01M 1.76M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
9.53M 4.77M 10.85M
Operating Cash Flow
-385.82M -228.01M -100.88M
Capital Expenditures
-2.92M -915K -3.07M
Cash Acquisitions
3.92M 1.22M 3.15M
Purchase of Investments
-1.52B -930.28M -400.83M
Sales Maturities Of Investments
1.36B 344.8M 381.21M
Other Investing Acitivies
-3.92M -1.22M -3.15M
Investing Cash Flow
-160.32M -586.39M -22.69M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
483.37M 855.78M 277.57M
Financial Cash Flow
483.37M 855.78M 277.57M
Net Cash Flow
-62.77M 41.38M 154.01M
Free Cash Flow
-388.74M -228.92M -103.95M